Cargando…
Similarities between COVID-19 and systemic sclerosis early vasculopathy: A “viral” challenge for future research in scleroderma
OBJECTIVE: To review similarities between COVID-19 and systemic sclerosis (SSc) early vasculopathy to provide novel insights into both diseases. METHODS: A narrative review of the literature supplemented with expert opinion. RESULTS: There is clear evidence that the endothelium is at the centre stag...
Autores principales: | Matucci-Cerinic, Marco, Hughes, Michael, Taliani, Gloria, Kahaleh, Bashar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier B.V.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8280663/ https://www.ncbi.nlm.nih.gov/pubmed/34274540 http://dx.doi.org/10.1016/j.autrev.2021.102899 |
Ejemplares similares
-
Epigenetic repression of bone morphogenetic protein receptor II expression in scleroderma
por: Wang, Yongqing, et al.
Publicado: (2013) -
Treatment of systemic sclerosis: is there any hope for the future?
por: Allanore, Yannick, et al.
Publicado: (2016) -
Phenotypes Determined by Cluster Analysis and Their Survival in the Prospective European Scleroderma Trials and Research Cohort of Patients With Systemic Sclerosis
por: Sobanski, Vincent, et al.
Publicado: (2019) -
Predictors of disease worsening defined by progression of organ damage in diffuse systemic sclerosis: a European Scleroderma Trials and Research (EUSTAR) analysis
por: Becker, Mike, et al.
Publicado: (2019) -
Systemic sclerosis (scleroderma): remaining challenges
por: Connolly, Mary Karin
Publicado: (2021)